treatment – Asian Pacific Journal of Allergy and Immunology

January 6, 2025

Chronic cough management: Practical guidelines and PICO-based evidence for treatment

This part reviews the management of chronic cough and proposes a management algorithm. Despite proven improvements in quality of life following chronic cough treatment, a clear understanding of the disease and the evidence for the efficacy of some treatments remain vague.

Chronic Cough, cough, evidence-based, guideline, PICO, treatment

November 12, 2023

Articular involvement in Henoch-Schönlein Purpura: A review of literature

Henoch-Schönlein purpura (HSP), the most typical kind of pediatric vasculitis, can also affect adults. Over the last 10 years, research has been increasing on improvements in HSP diagnosis, physiopathology, symptoms, and therapy. Joint involvement is highly frequent in this condition; however, it typically undergoes spontaneous resolution and does not lead to long-term complications.

arthralgia, arthritis, Henoch - Schoenlein purpura, IgA vasculitis, physiopathology, treatment

October 25, 2022

Real-life efficacy and drug continuation of secukinumab in treating moderate to severe plaque psoriasis in Aegean region of Turkey: a multicenter retrospective study and systematic review of the literature

Secukinumab was demonstrated to be efficient in the treatment of moderate to severe plaque psoriasis in the phase studies. Real-life treatment experiences obtained from patients that do not meet the inclusion criteria of phase studies can provide valuable information on efficacy and safety results. Results may also differ in different ethnic populations.

anti-IL17, biologics, psoriasis, real, real-life, real-world, secukinumab, treatment

May 30, 2022

Asia-Pacific survey of physicians’ perceptions and managements of chronic rhinosinusitis

The diagnosis and management of patients with chronic rhinosinusitis (CRS) may vary between otolaryngologists and allergists. Moreover, the adherence of different practitioners to European Position Paper on Rhinosinusitis and Nasal Polyps (EPOS)2020 guideline recommendations has not been previously ascertained in Asia-Pacific regions.

allergists, chronic rhinosinusitis, diagnosis, otolaryngologists, treatment

January 30, 2021

Efficacy of drug therapies in antihistamine refractory chronic spontaneous urticaria: Real life data

Omalizumab is a safe and effective treatment for antihistamine-refractory chronic spontaneous urticaria (CSU) but is insufficient in one-third of patients. For serious cases in which omalizumab is ineffective, cyclosporine or methotrexate may be preferred. Most drug trials in CSU have focused on omalizumab or cyclosporine monotherapy.

chronic spontaneous urticaria, cyclosporine, efficacy, methotrexate, Omalizumab, safety, treatment

July 18, 2020

A pilot study into bosentan (Tracleer®) as an immunomodulating agent in patients with Behçet’s disease

Behçet’s disease (BD) is an auto-inflammatory vasculitis characterized by aphthous oro-genital ulcers, inflammatory skin changes and uveitis. Treatment is mainly immunosuppressive. Interestingly, elevated endotheline-1 (ET-1) levels suggest a possible beneficial effect of treatment with an ET-1 receptor antagonist.

BDCAF, Behçet’s disease, bosentan, treatment, trial